6.60
Precedente Chiudi:
$6.76
Aprire:
$6.68
Volume 24 ore:
20,751
Relative Volume:
0.46
Capitalizzazione di mercato:
$57.43M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
+4.76%
1M Prestazione:
-9.96%
6M Prestazione:
+24.81%
1 anno Prestazione:
+4.75%
Neuehealth Inc Stock (NEUE) Company Profile
Nome
Neuehealth Inc
Settore
Industria
Telefono
612-238-1321
Indirizzo
9250 NW 36TH STREET, DORAL
Confronta NEUE con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
NEUE
Neuehealth Inc
|
6.60 | 57.43M | 0 | 0 | 0 | 0.00 |
![]()
UNH
Unitedhealth Group Inc
|
523.12 | 482.11B | 400.28B | 14.41B | 20.71B | 15.50 |
![]()
ELV
Elevance Health Inc
|
432.68 | 98.38B | 176.81B | 5.98B | 4.55B | 25.61 |
![]()
CI
Cigna Group
|
331.00 | 89.90B | 244.38B | 3.43B | 8.96B | 12.24 |
![]()
CVS
Cvs Health Corp
|
67.98 | 85.60B | 372.81B | 4.61B | 6.33B | 3.66 |
![]()
HUM
Humana Inc
|
264.74 | 31.89B | 117.76B | 1.21B | 2.39B | 9.95 |
Neuehealth Inc Stock (NEUE) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2022-10-11 | Downgrade | JP Morgan | Neutral → Underweight |
2022-03-29 | Downgrade | JP Morgan | Overweight → Neutral |
2022-03-04 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
2022-03-02 | Downgrade | BofA Securities | Buy → Underperform |
2022-01-10 | Ripresa | Citigroup | Neutral |
2021-12-16 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
2021-12-14 | Iniziato | Goldman | Neutral |
2021-12-10 | Aggiornamento | JP Morgan | Neutral → Overweight |
2021-11-12 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
2021-11-02 | Downgrade | Cowen | Outperform → Market Perform |
2021-11-01 | Downgrade | Citigroup | Buy → Neutral |
2021-09-10 | Iniziato | Cowen | Outperform |
2021-08-04 | Aggiornamento | Citigroup | Neutral → Buy |
2021-08-04 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
2021-07-19 | Iniziato | Goldman | Buy |
2021-07-19 | Iniziato | JP Morgan | Neutral |
2021-07-19 | Iniziato | Morgan Stanley | Equal-Weight |
2021-07-19 | Iniziato | Piper Sandler | Overweight |
2021-07-19 | Iniziato | RBC Capital Mkts | Outperform |
2021-07-19 | Iniziato | Wolfe Research | Peer Perform |
Mostra tutto
Neuehealth Inc Borsa (NEUE) Ultime notizie
Virtu Financial LLC Takes Position in NeueHealth, Inc. (NYSE:NEUE) - Defense World
NeueHealth, Inc. (NYSE:NEUE) Q4 2024 Earnings Call Transcript - MSN
NeueHealth Inc. Earnings Call Highlights Growth and Acquisition - TipRanks
NeueHealth Inc. (NEUE) reports earnings - Quartz
NeueHealth: Q4 Earnings Snapshot - Midland Daily News
NeueHealth Inc (NEUE) Q4 2024 Earnings Call Highlights: Record Revenue and Strategic Growth ... By GuruFocus - Investing.com Canada
NeueHealth Inc. Reports Strong 2024 Financial Performance - TipRanks
NeueHealth Inc reports results for the quarter ended December 31Earnings Summary - TradingView
NeueHealth Q4 Net Loss Narrows, Stock Up In Pre-market - Nasdaq
NEUEHEALTH Earnings Results: $NEUE Reports Quarterly Earnings - Nasdaq
NeueHealth Reports Fourth Quarter and Full Year 2024 Results - TradingView
NeueHealth Crushes Growth Targets: Consumer Base Surges 48% as 2024 Hits All-Time Highs - Stock Titan
NeueHealth reaches modified repayment agreement with CMS By Investing.com - Investing.com Australia
NeueHealth reaches modified repayment agreement with CMS - Investing.com India
NeueHealth IncOn March 13, Insurance Units Modify Repayment Agreements With CMSSEC Filing - Marketscreener.com
NeueHealth, Inc. (NYSE:NEUE) Short Interest Down 25.8% in February - Defense World
NeueHealth Executives Sell Shares Worth Over $411K - TradingView
neuehealth EVP Tomas Orozco sells $13,235 in stock By Investing.com - Investing.com South Africa
NeueHealth CFO Jay Matushak sells $16,892 in common stock By Investing.com - Investing.com Australia
NeueHealth CEO George Mikan sells $117,004 in stock By Investing.com - Investing.com Australia
Neuehealth’s chief accounting officer sells $5,523 in stock transactions By Investing.com - Investing.com South Africa
NeueHealth CFO Jay Matushak sells $16,892 in common stock - Investing.com India
Neuehealth’s chief accounting officer sells $5,523 in stock transactions - Investing.com India
neuehealth EVP Tomas Orozco sells $13,235 in stock - Investing.com India
neuehealth gc Craig Jeffery Michael sells $7,940 in stock - Investing.com
neuehealth gc Craig Jeffery Michael sells $7,940 in stock By Investing.com - Investing.com UK
NeueHealth CEO George Mikan sells $117,004 in stock - Investing.com
NeueHealth (NEUE) Expected to Announce Quarterly Earnings on Thursday - Defense World
NeueHealth CEO George Mikan III sells $203,009 in stock By Investing.com - Investing.com Australia
NeueHealth CEO George Mikan III sells $203,009 in stock - Investing.com India
NeueHealth EVP Tomas Orozco sells $4,599 in stock By Investing.com - Investing.com South Africa
NeueHealth GC Craig Michael sells $8,929 in stock By Investing.com - Investing.com South Africa
NeueHealth chief accounting officer sells $5,756 in stock - Investing.com India
NeueHealth GC Craig Michael sells $8,929 in stock - Investing.com India
Neuehealth CFO Matushak sells $14,672 in stock By Investing.com - Investing.com South Africa
NeueHealth chief accounting officer sells $5,756 in stock By Investing.com - Investing.com South Africa
NeueHealth Executives Sell Shares - TradingView
Neuehealth CFO Matushak sells $14,672 in stock - Investing.com
NeueHealth EVP Tomas Orozco sells $4,599 in stock - Investing.com
NeueHealth (NEUE) Projected to Post Earnings on Wednesday - Defense World
NeueHealth to Host Fourth Quarter 2024 Earnings Conference Call on March 20, 2025 - The Bakersfield Californian
When Will NeueHealth Reveal Its Q4 Performance? Key Date for Investors - StockTitan
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LBRDA, AMPS, NEUE on Behalf of Shareholders - Marketscreener.com
Quarterly Healthcare Transactions Review: Unveiling the Latest Industry Mergers and Acquisitions - Lexology
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ENFN, AZPN, HEES, NEUE on Behalf of Shareholders - Marketscreener.com
Neuehealth Inc Azioni (NEUE) Dati Finanziari
Non sono disponibili dati finanziari per Neuehealth Inc (NEUE). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):